SG Americas Securities’s Aclaris Therapeutics ACRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $76K | Sell |
53,359
-14,574
| -21% | -$20.8K | ﹤0.01% | 2372 |
|
|
2025
Q1 | $104K | Buy |
+67,933
| New | +$104K | ﹤0.01% | 2678 |
|
|
2024
Q2 | – | Sell |
-32,843
| Closed | -$41K | – | 2396 |
|
|
2024
Q1 | $41K | Buy |
32,843
+13,461
| +69% | +$16.8K | ﹤0.01% | 2456 |
|
|
2023
Q4 | $20K | Sell |
19,382
-132,322
| -87% | -$137K | ﹤0.01% | 2695 |
|
|
2023
Q3 | $1.04M | Buy |
151,704
+25,357
| +20% | +$174K | 0.01% | 1144 |
|
|
2023
Q2 | $1.31M | Buy |
126,347
+96,504
| +323% | +$1M | 0.01% | 851 |
|
|
2023
Q1 | $241K | Buy |
29,843
+22,482
| +305% | +$182K | ﹤0.01% | 2089 |
|
|
2022
Q4 | $116K | Sell |
7,361
-6,237
| -46% | -$98.3K | ﹤0.01% | 2383 |
|
|
2022
Q3 | $214K | Buy |
+13,598
| New | +$214K | ﹤0.01% | 2019 |
|
|
2022
Q1 | – | Sell |
-13,679
| Closed | -$199K | – | 2546 |
|
|
2021
Q4 | $199K | Sell |
13,679
-7,333
| -35% | -$107K | ﹤0.01% | 2405 |
|
|
2021
Q3 | $378K | Buy |
+21,012
| New | +$378K | ﹤0.01% | 2522 |
|
|
2020
Q2 | – | Sell |
-13,280
| Closed | -$14K | – | 3127 |
|
|
2020
Q1 | $14K | Buy |
+13,280
| New | +$14K | ﹤0.01% | 2802 |
|
|
2017
Q2 | – | Sell |
-13,968
| Closed | -$417K | – | 2636 |
|
|
2017
Q1 | $417K | Buy |
+13,968
| New | +$417K | ﹤0.01% | 1757 |
|